A visual guide to the immune mechanisms behind psoriasis, explained without jargon.
Your skin is the body's largest organ and its outermost barrier. Normally, skin cells (called keratinocytes) are produced at the base of the epidermis, slowly migrate upward over ~28 days, and quietly shed from the surface. In psoriasis, the immune system mistakenly accelerates this process to just 3β5 days, causing cells to pile up into thick, inflamed plaques.
Think of your skin as a conveyor belt in a factory. Normally, new tiles (skin cells) are placed on the belt at one end and fall off the other end at a steady pace. In psoriasis, someone has cranked the belt speed to 10Γ. Tiles pile up at the end because they can't fall off fast enough. Meanwhile, an overzealous security team (the immune system) keeps sounding false alarms, calling in more and more workers β making everything worse. The result: a chaotic pile-up that's red, raised, and inflamed.
This simplified cross-section compares normal skin with a psoriatic plaque.
Psoriasis develops through a chain reaction involving three main phases. Here's how a trigger becomes a plaque.
Something happens β an injury, a throat infection, stress, or a medication β that damages or stresses skin cells in a genetically susceptible person.
Imagine LL-37/DNA complexes as burnt toast smoke. In most people, the smoke detector (pDC) briefly beeps and resets. In someone with psoriasis genetics, the smoke detector is hypersensitive β it triggers the full building fire alarm (IFN-Ξ±), calling every fire engine in town.
The alarm signals activate the adaptive immune system, recruiting specialised T cells that drive the core inflammatory response.
IL-23 is like a drill sergeant turning recruits (naΓ―ve T cells) into a specialised assault force (Th17 cells). Those soldiers produce IL-17A β which is like a megaphone that tells the factory workers (keratinocytes) to speed up production AND to broadcast recruitment ads for more soldiers. Each new soldier brings another megaphone.
The inflammatory response becomes self-sustaining β a feedback loop that maintains the psoriatic plaque indefinitely.
TRM cells are like sticky notes left on the inside of your skin that say "there was a problem here." Even after the plaque clears with treatment, the notes remain. Any small provocation causes the immune system to read the note and restart the entire inflammatory programme β which is why psoriasis keeps coming back to the same spots.
The core mechanism of psoriasis is a circular chain reaction. This is the cycle that biologic therapies aim to break.
Each class of biologic drug works by cutting a specific link in this chain. IL-23 inhibitors (like Skyrizi) cut the signal that creates Th17 cells. IL-17 inhibitors (like Cosentyx) block the main weapon those Th17 cells use. TNF-Ξ± inhibitors (like Humira) dampen the broader inflammatory amplification. The more upstream you cut (IL-23), the more completely the downstream cascade collapses β which is why IL-23 inhibitors tend to be the most effective.